HEMOPHILIA A AND B
-
UPDATE – Supply of DDAVP injectable discontinued
Ferring says supply of DDAVP injectable to return in “one to two months” Montreal, June 23, 2021 – Ferring Canada, in discussions with the Canadian...
-
Novel treatments in bleeding disorders: The European Haemophilia Consortium Review
CLICK HERE to access the June 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
-
CHS 5-year strategic framework officially launched!
The CHS is pleased to share its brand new five-year strategic framework following an extensive strategic planning exercise held in 2020. The strategy is expressed...
-
UPDATED Access to Hemlibra: Decisions from provincial/territorial governments expected in coming weeks
On May 25, 2021, Canadian Blood Services (CBS) released its report on emicizumab (Hemlibra) to the provincial/territorial (P/T) Ministers of Health (except Quebec), recommending eligibility...
-
CBS recommends emicizumab (Hemlibra) to Ministers of Health
On May 25, 2021, Canadian Blood Services (CBS) released its recommendation on emicizumab (Hemlibra) to the provincial/territorial Ministers of Health. CBS recommends that emicizumab be listed...